|
|
|
40
|
22411
|
FRAMOPTIC D EYE DR (ASL/PHA) DEX/FRAMY/GRAMI
|
DEXAMETHASONE|FRAMYCETIN|GRAMICIDIN
|
FRAMOPTIC D
|
10ML
|
C
|
8.07
|
8.07
|
EYE DROP
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
22411
|
FRAMOPTIC D 0.05%|0.5%|0.005% EYE/EAR DR (ASL) DEXAMETHASONE (C)
|
DEXAMETHASONE|FRAMYCETIN|GRAMICIDIN
|
FRAMOPTIC D
|
10ML
|
C
|
12.72
|
12.7218
|
BOTT
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
22411
|
FRAMOPTIC D 0.05%|0.5%|0.005% EYE/EAR DR (ASL) DEXAMETHASONE
|
DEXAMETHASONE|FRAMYCETIN|GRAMICIDIN
|
FRAMOPTIC D
|
10ML
|
C
|
11.55
|
11.55
|
BOTT
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
2491AD
|
DEXAMETHASONE SODIUM PHOSPHATE 4MG/ML IV/IM INJ (RTM/PHA)
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMETHASONE SODIUM PHOSPHATE
|
10X1ML
|
B
|
10.87
|
1.09
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2491AD
|
DEXAMET. SOD. PHOS. 4MG/ML IV/IM INJ (RTM)
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMETHASONE SODIUM PHOSPHATE
|
10X1ML
|
BQ
|
14.92
|
1.4924
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
2024-02-08
|
|
|
|
42
|
2491AD
|
DEXAMET. SOD. PHOS. 4MG/ML IV/IM INJ (RTM)
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMETHASONE SODIUM PHOSPHATE
|
10X1ML
|
B
|
12.50
|
1.25
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
41
|
2491AR
|
DEXAMET. SOD. PHOS. 4MG/ML IV/IM INJ (KR (B)
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMET. SOD. PHOS.
|
25X1ML
|
B
|
16.31
|
0.6524
|
AMP
|
0
|
BOX
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
41
|
24922
|
DEXAMET. SOD. PHOS. 10MG/ML IV/IM INJ (OMG) DEXAMETHASONE SO (B)
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMET. SOD. PHOS.
|
10X1ML
|
B
|
47.35
|
4.7353
|
VIAL
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
42
|
24922
|
DEXAMET. SOD. PHOS. 10MG/ML IV/IM INJ (OMG) DEXAMETHASONE SO
|
DEXAMETHASONE SODIUM PHOSPHATE
|
DEXAMET. SOD. PHOS.
|
10X1ML
|
B
|
76.11
|
7.61
|
VIAL
|
0
|
VIAL
|
OMG
|
OMEGA
|
COL
|
AVENTA BARBADOS
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
40
|
26613
|
PMS-DEXAMETHASONE 0.5MG TAB (PMS/COL)
|
DEXAMETHASONE
|
PMS-DEXAMETHASONE
|
100'S
|
A
|
8.43
|
0.08
|
TABLET
|
90
|
TAB
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
26614
|
APO-DEXAMETHASONE 0.5MG TAB (APO/COL)
|
DEXAMETHASONE
|
APO-DEXAMETHASONE
|
100'S
|
A
|
8.43
|
0.08
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
26614
|
APO-DEXAMETHASONE 0.5MG TAB (APO)
|
DEXAMETHASONE
|
APO-DEXAMETHASONE
|
100'S
|
A
|
8.43
|
0.08
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
ORAL
|
6
|
ADRENALS
|
|
|
|
|
41
|
2661S
|
APO-DEXAMETHASONE 0.5MG TAB (APO)
|
DEXAMETHASONE
|
APO-DEXAMETHASONE
|
100'S
|
A
|
8.59
|
0.0859
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ADRENALS
|
|
|
|
|
40
|
2662E
|
SONEXA 0.1% EYE DR (ARP/AHI) DEXAMETHASONE
|
DEXAMETHASONE
|
SONEXA
|
5ML
|
B
|
4.57
|
4.57
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
42
|
2662E
|
SONEXA 0.1% EYE DR (ARP) DEXAMETHAS
|
DEXAMETHASONE
|
SONEXA
|
5ML
|
B
|
4.05
|
4.05
|
BOTT
|
1
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
2662F
|
MONODEXA 0.1% EYE DR (SHC) DEXAMETHASONE (B)
|
DEXAMETHASONE
|
MONODEXA
|
5ML
|
B
|
4.08
|
4.0775
|
BOTT
|
1
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
2662F
|
MONODEXA 0.1% EYE DR (SHC) DEXAMETHASONE
|
DEXAMETHASONE
|
MONODEXA
|
5ML
|
B
|
4.08
|
4.08
|
BOTT
|
1
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
26636
|
APO-DEXAMETHASONE 4MG TAB (APO/COL)
|
DEXAMETHASONE
|
APO-DEXAMETHASONE
|
100'S
|
A
|
21.20
|
0.21
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
26636
|
APO-DEXAMETHASONE 4MG TAB (APO)
|
DEXAMETHASONE
|
APO-DEXAMETHASONE
|
100'S
|
A
|
21.20
|
0.21
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
ORAL
|
6
|
ADRENALS
|
|
|
|
|
42
|
26637
|
PMS-DEXAMETHASONE 4MG TAB (PMS)
|
DEXAMETHASONE
|
PMS-DEXAMETHASONE
|
100'S
|
A
|
16.31
|
0.16
|
TAB
|
90
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
6804
|
ADRENALS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ADRENALS
|
|
